- Home
- BKTI vs VTYX Comparison
BKTI vs VTYX Comparison
Compare BKTI & VTYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKTI
- VTYX
- Stock Information
- Founded
- BKTI 1997
- VTYX 2018
- Country
- BKTI United States
- VTYX United States
- Employees
- BKTI N/A
- VTYX N/A
- Industry
- BKTI Radio And Television Broadcasting And Communications Equipment
- VTYX Medicinal Chemicals and Botanical Products
- Sector
- BKTI Technology
- VTYX Health Care
- Exchange
- BKTI Nasdaq
- VTYX Nasdaq
- Market Cap
- BKTI 156.7M
- VTYX 154.9M
- IPO Year
- BKTI N/A
- VTYX 2021
- Fundamental
- Price
- BKTI $52.96
- VTYX $2.08
- Analyst Decision
- BKTI Strong Buy
- VTYX Buy
- Analyst Count
- BKTI 1
- VTYX 4
- Target Price
- BKTI $55.00
- VTYX $11.33
- AVG Volume (30 Days)
- BKTI 101.2K
- VTYX 2.3M
- Earning Date
- BKTI 08-07-2025
- VTYX 08-07-2025
- Dividend Yield
- BKTI N/A
- VTYX N/A
- EPS Growth
- BKTI N/A
- VTYX N/A
- EPS
- BKTI 2.59
- VTYX N/A
- Revenue
- BKTI $77,415,000.00
- VTYX N/A
- Revenue This Year
- BKTI $8.80
- VTYX N/A
- Revenue Next Year
- BKTI $8.69
- VTYX N/A
- P/E Ratio
- BKTI $19.43
- VTYX N/A
- Revenue Growth
- BKTI 5.18
- VTYX N/A
- 52 Week Low
- BKTI $11.67
- VTYX $0.78
- 52 Week High
- BKTI $58.00
- VTYX $3.39
- Technical
- Relative Strength Index (RSI)
- BKTI 54.85
- VTYX 47.92
- Support Level
- BKTI $44.50
- VTYX $1.95
- Resistance Level
- BKTI $56.95
- VTYX $2.51
- Average True Range (ATR)
- BKTI 4.48
- VTYX 0.19
- MACD
- BKTI -0.12
- VTYX -0.08
- Stochastic Oscillator
- BKTI 53.67
- VTYX 19.12
About BKTI BK Technologies Corporation
BK Technologies Corp a holding company, operates through its subsidiary, BK Technologies, Inc., specializing in designing, manufacturing, and marketing wireless communications equipment. Its Radio business unit offers two-way land mobile radios (LMRs) serving government and public safety markets, as well as industrial and commercial enterprises. The SaaS business unit focuses on public safety smartphone applications, enhancing first responders' safety and efficiency. The BKRplay application, tethered to BK radios, amplifies user capabilities, expanding the reach of their radio sales. Its product portfolio consists of two-way land mobile radios, handheld radios, radios installed in vehicles.
About VTYX Ventyx Biosciences Inc.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.